[{"address1": "120 S. Sierra Avenue", "address2": "Suite 100", "city": "Solana Beach", "state": "CA", "zip": "92075", "country": "United States", "phone": "888 287 9109", "website": "https://www.clearpointneuro.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.", "fullTimeEmployees": 107, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph Michael Burnett", "age": 47, "title": "President, CEO & Director", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 803116, "exercisedValue": 0, "unexercisedValue": 1934385}, {"maxAge": 1, "name": "Mr. Danilo  D'Alessandro", "age": 39, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 459257, "exercisedValue": 0, "unexercisedValue": 74250}, {"maxAge": 1, "name": "Mr. Jeremy  Stigall", "age": 40, "title": "Chief Business Officer", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 392656, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mazin  Sabra", "age": 43, "title": "Chief Operating Officer", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ellisa  Cholapranee J.D.", "title": "General Counsel & Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jacqueline  Keller", "title": "Vice President of Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 15.07, "open": 14.83, "dayLow": 14.31, "dayHigh": 14.8772, "regularMarketPreviousClose": 15.07, "regularMarketOpen": 14.83, "regularMarketDayLow": 14.31, "regularMarketDayHigh": 14.8772, "beta": 1.108, "forwardPE": -25.16586, "volume": 199888, "regularMarketVolume": 199888, "averageVolume": 243844, "averageVolume10days": 202160, "averageDailyVolume10Day": 202160, "bid": 14.59, "ask": 14.78, "bidSize": 100, "askSize": 100, "marketCap": 404943392, "fiftyTwoWeekLow": 5.11, "fiftyTwoWeekHigh": 17.47, "priceToSalesTrailing12Months": 13.307812, "fiftyDayAverage": 13.6142, "twoHundredDayAverage": 9.594, "currency": "USD", "enterpriseValue": 387064384, "profitMargins": -0.59637, "floatShares": 25424541, "sharesOutstanding": 27584700, "sharesShort": 744188, "sharesShortPriorMonth": 759900, "sharesShortPreviousMonthDate": 1731628800, "dateShortInterest": 1734048000, "sharesPercentSharesOut": 0.027, "heldPercentInsiders": 0.07831, "heldPercentInstitutions": 0.3048, "shortRatio": 3.01, "shortPercentOfFloat": 0.0277, "impliedSharesOutstanding": 28317500, "bookValue": 1.051, "priceToBook": 13.96765, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -18147000, "trailingEps": -0.69, "forwardEps": -0.61, "lastSplitFactor": "1:40", "lastSplitDate": 1469577600, "enterpriseToRevenue": 12.72, "enterpriseToEbitda": -21.594, "52WeekChange": 0.94437087, "SandP52WeekChange": 0.22263205, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CLPT", "underlyingSymbol": "CLPT", "shortName": "ClearPoint Neuro Inc.", "longName": "ClearPoint Neuro, Inc.", "firstTradeDateEpochUtc": 1337693400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "71a1dc2f-d47a-37fe-a48e-e2b464988296", "messageBoardId": "finmb_1432648", "gmtOffSetMilliseconds": -18000000, "currentPrice": 14.68, "targetHighPrice": 17.0, "targetLowPrice": 17.0, "targetMeanPrice": 17.0, "targetMedianPrice": 17.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 21573000, "totalCashPerShare": 0.782, "ebitda": -17925000, "totalDebt": 3694000, "quickRatio": 3.456, "currentRatio": 4.545, "totalRevenue": 30429000, "debtToEquity": 12.737, "revenuePerShare": 1.158, "returnOnAssets": -0.28038, "returnOnEquity": -0.68357, "freeCashflow": -1287000, "operatingCashflow": -8876000, "revenueGrowth": 0.41, "grossMargins": 0.6038, "ebitdaMargins": -0.58908004, "operatingMargins": -0.63679004, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-11"}]